Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesmTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary
Clinical Cancer Research, 09/08/09
Mabuchi S et al. – mTOR is frequently activated in clear cell carcinoma and can be a promising therapeutic target in the management of clear cell carcinoma. Moreover, mTOR inhibition by RAD001 may be efficacious as a second–line treatment of recurrent disease in patients previously treated with cisplatin.
Related Articles
Targeting the mTOR Pathway in Neuroendocrine Tumors
Clinical Journal of Oncology Nursing, 10/07/09
Relevance Score: 91%
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy
Journal of Hematology & Oncology, 10/30/09
Relevance Score: 90%
Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition
Proceedings of the National Academy of Sciences of the United States of America, 11/18/09
Relevance Score: 89%
The multiple facets of mTOR in immunity
Trends in Immunology, 10/08/09
Relevance Score: 89%
The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease
Journal of the American Society of Nephrology, 11/04/09
Relevance Score: 87%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Knockdown of peroxisome proliferator-activated receptor-beta induces less differentiation and enhances cell–fibronectin adhesion of colon cancer cells
Oncogene, 11/25/09
A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy
Oncogene, 11/25/09
Embryoid body formation of human amniotic fluid stem cells depends on mTOR
Oncogene, 11/25/09
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis
Oncogene, 11/25/09
Paracentesis in Ovarian Cancer: A Study of the Physiology during Free Drainage of Ascites
Journal of Palliative Medicine, 11/25/09
How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component
Clinical and Translational Oncology, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor